According to him, is preparing a package of documents defining the Protocol of research – in this work the participation of leading pediatric institutions in Russia. “These professionals have extensive experience in conducting clinical trials of new drugs for children,” – said the academician.
He also said that clinical trials of the children’s version of the vaccine will begin after completion of studies in adults – this can occur in four to six months.
Research involving children will be carried out in phases: starting with the older age group under the age of 18, then mounts the adolescents of 12-14 years and in the end a vaccine will apply to younger children.
Gunzburg also said that children will be given exactly the same composition of vaccine. as adults, “but it is necessary to specify the dosage and the scheme of introduction,” – said the scientist.
